Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma

spa:El cáncer de esófago es el octavo tipo de cáncer más frecuente en el mundo y el sexto causa de muerte por cáncer, con distribuciones variables según zonas geográficas región. Iniciativas para la detección precoz, tratamiento, control y seguimiento de diferentes patologías ha demostrado un impact...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2022
Institución:
Universidad de Caldas
Repositorio:
Repositorio Institucional U. Caldas
Idioma:
eng
spa
OAI Identifier:
oai:repositorio.ucaldas.edu.co:ucaldas/17396
Acceso en línea:
https://repositorio.ucaldas.edu.co/handle/ucaldas/17396
https://repositorio.ucaldas.edu.co/
Palabra clave:
Cáncer
Esófago-enfermedades
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
id REPOUCALDA_5cb8771fb7d466520800f90b5cab76ae
oai_identifier_str oai:repositorio.ucaldas.edu.co:ucaldas/17396
network_acronym_str REPOUCALDA
network_name_str Repositorio Institucional U. Caldas
repository_id_str
dc.title.none.fl_str_mv Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
title Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
spellingShingle Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
Cáncer
Esófago-enfermedades
title_short Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
title_full Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
title_fullStr Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
title_full_unstemmed Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
title_sort Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
dc.contributor.none.fl_str_mv Arango Molano, Lázaro Antonio
dc.subject.none.fl_str_mv Cáncer
Esófago-enfermedades
topic Cáncer
Esófago-enfermedades
description spa:El cáncer de esófago es el octavo tipo de cáncer más frecuente en el mundo y el sexto causa de muerte por cáncer, con distribuciones variables según zonas geográficas región. Iniciativas para la detección precoz, tratamiento, control y seguimiento de diferentes patologías ha demostrado un impacto significativo en la reducción de la morbilidad y la mortalidad en diferentes patologías, aunque no existen protocolos establecidos para el esófago tamizaje de cáncer en población general, factores de riesgo asociados al desarrollo de esta condición están bien definidos, y esto permite identificar y priorizar la población con mayor riesgo.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-11T00:04:37Z
2022-02-11T00:04:37Z
2022-01-05
dc.type.none.fl_str_mv Artículo de revista
http://purl.org/coar/resource_type/c_6501
Text
info:eu-repo/semantics/bachelorThesis
https://purl.org/redcol/resource_type/TP
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.identifier.none.fl_str_mv https://repositorio.ucaldas.edu.co/handle/ucaldas/17396
Universidad de Caldas
Repositorio institucional Universidad de Caldas
https://repositorio.ucaldas.edu.co/
url https://repositorio.ucaldas.edu.co/handle/ucaldas/17396
https://repositorio.ucaldas.edu.co/
identifier_str_mv Universidad de Caldas
Repositorio institucional Universidad de Caldas
dc.language.none.fl_str_mv eng
spa
language eng
spa
dc.relation.none.fl_str_mv 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2. Zakko, L; Lutzke, L; Wang K. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am. 2017;26(2):163–78.
3. Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res. 2016;113:236–44.
4. Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg. 2003;76(4):1367–9.
5. Njei B, Mccarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–6.
6. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol [Internet]. 2020;13(6):1010–21.
7. Coleman HG, Xie SH, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology [Internet]. 2018;154(2):390–405. Available from: https://doi.org/10.1053/j.gastro.2017.07.046
8. Chen T, Cheng H, Chen X, Yuan Z, Yang X, Zhuang M, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep [Internet]. 2015;5(July):1–9.
9. Turati F, Negri E, Vecchia C La. Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther. 2014;14(1):1–4.
10. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the international BEACON consortium. Int J Epidemiol. 2012;41(6):1706–18.
11. Choi YJ, Lee DH, Han K Do, Kim HS, Yoon H, Shin CM, et al. Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea (PLoS ONE (2017) 12:10 (e0185778) DOI: 10.1371/journal.pone.0185778). PLoS One. 2018;13(5):1–13.
12. Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions. J Nutr. 2020;150(4):663–71.
13. Cook MB, Thrift AP. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am [Internet]. 2021;31(1):1–26.
14. Kate Shannon . GODPJSJMCFRN. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015;44(2):203–31.
15. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol [Internet]. 2016;111(1):30–50.
16. Mohy-ud-din N, Krill TS, Shah AR, Chatila AT, Singh S, Bilal M, et al. Barrett’s esophagus: What do we need to know? Disease-a-Month. 2020;66(1):1–12
17. AmaDi C Di, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol. 2017;23(28):5051–67
18. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol. 2000;95(11):3089–96
19. Naini B V., Chak A, Ali MA, Odze RD. Barrett’s oesophagus diagnostic criteria: Endoscopy and histology. Best Pract Res Clin Gastroenterol [Internet]. 2015;29(1):77–96.
20. Horvath B, Singh P, Xie H, Thota PN, Allende DS, Pai RK, et al. Risk for esophageal neoplasia in Barrett’s esophagus patients with mucosal changes indefinite for dysplasia. J Gastroenterol Hepatol. 2015;30(2):262–7
21. Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett’s Esophagus With Dysplasia and/or Early Cancer: Expert Review. Gastroenterology [Internet]. 2020;158(3):760–9
22. Fitzgerald RC, Di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.
23. Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol [Internet]. 2012;9(5):278–87
24. Yang J, Wei WQ, Niu J, Liu ZC, Yang CX, Qiao YL. Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China. World J Gastroenterol. 2012;18(20):2493–501.
25. Spataro J, Zfass AM, Schubert M, Shah T. Early Esophageal Cancer: A Gastroenterologist’s Disease. Dig Dis Sci [Internet]. 2019;64(11):3048–58.
26. Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg [Internet]. 2015;99(6):1879–86
27. Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20(9).
28. Kim JA, Shah PM. Screening and prevention strategies and endoscopic management of early esophageal cancer. Chinese Clin Oncol. 2017;6(5):1– 11.
29. Sun F, Yuan P, Chen T, Hu J. Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: A systematic review and meta-analysis. J Cardiothorac Surg. 2014;9(1).
30. Halpern AL, McCarter MD. Palliative Management of Gastric and Esophageal Cancer. Surg Clin North Am [Internet]. 2019;99(3):555–69.
31. Kim JY, Kim SG, Lim JH, Im JP, Kim JS, Jung HC. Clinical outcomes of esophageal stents in patients with malignant esophageal obstruction according to palliative additional treatment. J Dig Dis. 2015;16(10):575–84.
dc.rights.none.fl_str_mv info:eu-repo/semantics/closedAccess
info:eu-repo/semantics/closedAccess
info:eu-repo/semantics/closedAccess
info:eu-repo/semantics/closedAccess
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_14cb
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Facultad de Ciencias Para la Salud
Manizales
Especialización Gastroenterología Clínico Quirúrgica
publisher.none.fl_str_mv Facultad de Ciencias Para la Salud
Manizales
Especialización Gastroenterología Clínico Quirúrgica
institution Universidad de Caldas
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1836145109821816832
spelling Risk Factors and Screening Strategies for Early Detection of Esophageal CarcinomaCáncerEsófago-enfermedadesspa:El cáncer de esófago es el octavo tipo de cáncer más frecuente en el mundo y el sexto causa de muerte por cáncer, con distribuciones variables según zonas geográficas región. Iniciativas para la detección precoz, tratamiento, control y seguimiento de diferentes patologías ha demostrado un impacto significativo en la reducción de la morbilidad y la mortalidad en diferentes patologías, aunque no existen protocolos establecidos para el esófago tamizaje de cáncer en población general, factores de riesgo asociados al desarrollo de esta condición están bien definidos, y esto permite identificar y priorizar la población con mayor riesgo.eng:Esophageal cancer is the 8th most frequent type of cancer in the world and the 6th cause of death from cancer, with variable distributions according to geographic region, it ́s mortality rate remains high because is rarely diagnosed at early stages. It has been reported that nearly 40% of patients have metastasized at the time of diagnosis; this added to the special anatomical conditions of the mediastinum and the high recurrence rate, confers it a worse prognosis and 5-year survival rate close to 20%. Initiatives for early detection, treatment, control and monitoring of different pathologies has shown a significant impact on reduction of morbidity and mortality in different pathologies, although there are no established protocols for esophageal cancer screening in general population, risks factors associated with development of this condition are well defined, and this allows identify and prioritize population with highest riskEspecializaciónEspecialilista en Gastroenterología Clínico QuirúrgicaFacultad de Ciencias Para la SaludManizalesEspecialización Gastroenterología Clínico QuirúrgicaArango Molano, Lázaro AntonioBautista Parada, Ileana RocioArango Molano, Lázaro Antonio2022-02-11T00:04:37Z2022-02-11T00:04:37Z2022-01-05Artículo de revistahttp://purl.org/coar/resource_type/c_6501Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_7a1fapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttps://repositorio.ucaldas.edu.co/handle/ucaldas/17396Universidad de CaldasRepositorio institucional Universidad de Caldashttps://repositorio.ucaldas.edu.co/engspa1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.2. Zakko, L; Lutzke, L; Wang K. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am. 2017;26(2):163–78.3. Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res. 2016;113:236–44.4. Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg. 2003;76(4):1367–9.5. Njei B, Mccarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–6.6. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol [Internet]. 2020;13(6):1010–21.7. Coleman HG, Xie SH, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology [Internet]. 2018;154(2):390–405. Available from: https://doi.org/10.1053/j.gastro.2017.07.0468. Chen T, Cheng H, Chen X, Yuan Z, Yang X, Zhuang M, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep [Internet]. 2015;5(July):1–9.9. Turati F, Negri E, Vecchia C La. Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther. 2014;14(1):1–4.10. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the international BEACON consortium. Int J Epidemiol. 2012;41(6):1706–18.11. Choi YJ, Lee DH, Han K Do, Kim HS, Yoon H, Shin CM, et al. Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea (PLoS ONE (2017) 12:10 (e0185778) DOI: 10.1371/journal.pone.0185778). PLoS One. 2018;13(5):1–13.12. Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions. J Nutr. 2020;150(4):663–71.13. Cook MB, Thrift AP. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am [Internet]. 2021;31(1):1–26.14. Kate Shannon . GODPJSJMCFRN. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015;44(2):203–31.15. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol [Internet]. 2016;111(1):30–50.16. Mohy-ud-din N, Krill TS, Shah AR, Chatila AT, Singh S, Bilal M, et al. Barrett’s esophagus: What do we need to know? Disease-a-Month. 2020;66(1):1–1217. AmaDi C Di, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol. 2017;23(28):5051–6718. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol. 2000;95(11):3089–9619. Naini B V., Chak A, Ali MA, Odze RD. Barrett’s oesophagus diagnostic criteria: Endoscopy and histology. Best Pract Res Clin Gastroenterol [Internet]. 2015;29(1):77–96.20. Horvath B, Singh P, Xie H, Thota PN, Allende DS, Pai RK, et al. Risk for esophageal neoplasia in Barrett’s esophagus patients with mucosal changes indefinite for dysplasia. J Gastroenterol Hepatol. 2015;30(2):262–721. Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett’s Esophagus With Dysplasia and/or Early Cancer: Expert Review. Gastroenterology [Internet]. 2020;158(3):760–922. Fitzgerald RC, Di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.23. Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol [Internet]. 2012;9(5):278–8724. Yang J, Wei WQ, Niu J, Liu ZC, Yang CX, Qiao YL. Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China. World J Gastroenterol. 2012;18(20):2493–501.25. Spataro J, Zfass AM, Schubert M, Shah T. Early Esophageal Cancer: A Gastroenterologist’s Disease. Dig Dis Sci [Internet]. 2019;64(11):3048–58.26. Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg [Internet]. 2015;99(6):1879–8627. Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20(9).28. Kim JA, Shah PM. Screening and prevention strategies and endoscopic management of early esophageal cancer. Chinese Clin Oncol. 2017;6(5):1– 11.29. Sun F, Yuan P, Chen T, Hu J. Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: A systematic review and meta-analysis. J Cardiothorac Surg. 2014;9(1).30. Halpern AL, McCarter MD. Palliative Management of Gastric and Esophageal Cancer. Surg Clin North Am [Internet]. 2019;99(3):555–69.31. Kim JY, Kim SG, Lim JH, Im JP, Kim JS, Jung HC. Clinical outcomes of esophageal stents in patients with malignant esophageal obstruction according to palliative additional treatment. J Dig Dis. 2015;16(10):575–84.info:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cboai:repositorio.ucaldas.edu.co:ucaldas/173962024-07-16T21:51:45Z

Publicaciones similares